MiMedx Group (MDXG) News Today $7.76 +0.05 (+0.65%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 7:51 PM | markets.businessinsider.comCraig-Hallum Gives a Buy Rating to MiMedx Group (MDXG)July 24 at 8:03 AM | marketbeat.comMiMedx Group (MDXG) to Release Earnings on WednesdayMiMedx Group (NASDAQ:MDXG) will be releasing earnings after the market closes on Wednesday, July 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=609535)July 22, 2024 | globenewswire.comMIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific ReportsJuly 19, 2024 | finance.yahoo.comMIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31July 11, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Rating Increased to Strong-Buy at StockNews.comStockNews.com raised shares of MiMedx Group from a "buy" rating to a "strong-buy" rating in a research note on Thursday.July 10, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Receives Average Rating of "Buy" from AnalystsMiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) has earned a consensus recommendation of "Buy" from the five research firms that are covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers thJuly 7, 2024 | marketbeat.comPrincipal Financial Group Inc. Trims Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG)Principal Financial Group Inc. decreased its position in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 63.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 66,000 shares of the company's stock after selling 116,526 shares during the period. PrincJuly 3, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Rating Lowered to Buy at StockNews.comStockNews.com downgraded shares of MiMedx Group from a "strong-buy" rating to a "buy" rating in a research note on Wednesday.July 2, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Now Covered by Analysts at Cantor FitzgeraldCantor Fitzgerald started coverage on MiMedx Group in a research note on Tuesday. They issued an "overweight" rating and a $11.00 price objective on the stock.July 1, 2024 | investorplace.com7 Undervalued Biotech Stocks to Buy for Big-Time ReturnsJune 26, 2024 | globenewswire.comMIMEDX Announces the Appointment of Kim Moller to Chief Commercial OfficerJune 3, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Upgraded at StockNews.comStockNews.com upgraded MiMedx Group from a "buy" rating to a "strong-buy" rating in a report on Monday.May 30, 2024 | marketbeat.comIsthmus Partners LLC Cuts Position in MiMedx Group, Inc. (NASDAQ:MDXG)Isthmus Partners LLC decreased its holdings in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 42.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 216,211 shares of the company's stock after selling 160,010 shares during the quartMay 27, 2024 | msn.comCompare with MiMedx Group Inc (MDXG)May 20, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Hillsdale Investment Management Inc.Hillsdale Investment Management Inc. increased its stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 69.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 447,900 shares of the company's stoMay 15, 2024 | globenewswire.comMIMEDX to Participate in Upcoming Investor ConferencesMay 11, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Russell Investments Group Ltd.Russell Investments Group Ltd. lifted its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 1,577.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 525,059 shares of the company's stock after buying an addiMay 3, 2024 | marketbeat.comStockNews.com Lowers MiMedx Group (NASDAQ:MDXG) to BuyStockNews.com downgraded shares of MiMedx Group from a "strong-buy" rating to a "buy" rating in a research report on Friday.May 3, 2024 | marketbeat.comEquities Analysts Set Expectations for MiMedx Group, Inc.'s FY2026 Earnings (NASDAQ:MDXG)MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - Equities researchers at Zacks Small Cap issued their FY2026 earnings estimates for MiMedx Group in a report released on Wednesday, May 1st. Zacks Small Cap analyst J. Vandermosten expects that the company will post earnings per share of $1.04 for tMay 2, 2024 | finance.yahoo.comMiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comMiMedx Group, Inc. to Post Q4 2024 Earnings of $0.11 Per Share, HC Wainwright Forecasts (NASDAQ:MDXG)MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - HC Wainwright lowered their Q4 2024 EPS estimates for shares of MiMedx Group in a research note issued on Wednesday, May 1st. HC Wainwright analyst S. Ramakanth now expects that the company will earn $0.11 per share for the quarter, down from theirMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for MiMedx on Strong Performance and Favorable Market OutlookMay 1, 2024 | finance.yahoo.comMDXG: MACs Give Credit for EfficacyMay 1, 2024 | markets.businessinsider.comMiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy RatingMay 1, 2024 | finance.yahoo.comQ1 2024 MiMedx Group Inc Earnings CallMay 1, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and set a $11.00 target price on shares of MiMedx Group in a research report on Wednesday.May 1, 2024 | finanznachrichten.deMiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial ResultsMay 1, 2024 | finance.yahoo.comMiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...April 30, 2024 | markets.businessinsider.comMDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | globenewswire.comMIMEDX Announces First Quarter 2024 Operating and Financial ResultsApril 29, 2024 | markets.businessinsider.comMiMedx Group earnings preview: what Wall Street is expectingApril 27, 2024 | nasdaq.comMiMedx Group Enters Oversold Territory (MDXG)April 25, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Shares Gap Down to $6.43MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $6.43April 23, 2024 | money.usnews.comMimedx Group IncApril 23, 2024 | marketbeat.comMiMedx Group (MDXG) Set to Announce Quarterly Earnings on TuesdayMiMedx Group (NASDAQ:MDXG) will be releasing earnings after the market closes on Tuesday, April 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=585103)April 21, 2024 | marketbeat.comCalamos Advisors LLC Invests $3.12 Million in MiMedx Group, Inc. (NASDAQ:MDXG)Calamos Advisors LLC bought a new position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 355,534 shares of the company'sApril 18, 2024 | fool.comMiMedx Group (NASDAQ: MDXG)April 16, 2024 | globenewswire.comMIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30April 13, 2024 | wsj.comMiMedx Group Inc.April 10, 2024 | marketbeat.comVanguard Group Inc. Acquires 250,812 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)Vanguard Group Inc. grew its holdings in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 4.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,437,155 shares of the company's stock after acquiring an additional 250,812 shares during the period.April 9, 2024 | marketbeat.comTurtle Creek Wealth Advisors LLC Takes Position in MiMedx Group, Inc. (NASDAQ:MDXG)Turtle Creek Wealth Advisors LLC acquired a new stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 181,700 shares of the company's stock, valued at approximately $1,59April 2, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Shares Down 7.5% MiMedx Group (NASDAQ:MDXG) Trading Down 7.5%March 29, 2024 | stockhouse.comMIMEDX Provides Update on AXIOFILL® Request for Designation ("RFD") from FDAMarch 27, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Sees Large Volume IncreaseMiMedx Group (NASDAQ:MDXG) Sees Large Volume IncreaseMarch 27, 2024 | msn.comMiMedx slips as FDA reaffirms position on AxiofillMarch 27, 2024 | finance.yahoo.comMIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDAMarch 22, 2024 | investing.comMiMedx secures exclusive rights to wound care productMarch 21, 2024 | markets.businessinsider.comNorthland Securities Keeps Their Buy Rating on MiMedx Group (MDXG)March 21, 2024 | finance.yahoo.comInvesting in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gainMarch 20, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG) Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! MDXG Media Mentions By Week MDXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDXG News Sentiment▼0.470.62▲Average Medical News Sentiment MDXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDXG Articles This Week▼42▲MDXG Articles Average Week Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vapotherm News Inspire Medical Systems News PROCEPT BioRobotics News Axonics News Inari Medical News iRhythm Technologies News ICU Medical News Tandem Diabetes Care News UFP Technologies News Integra LifeSciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDXG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
